KALA BIO, Inc. (KALA) vs Moleculin Biotech, Inc. (MBRX)
KALA BIO, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. KALA BIO, Inc. and Moleculin Biotech, Inc. are of similar size ($11.2M and $10.7M). KALA BIO, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, KALA BIO, Inc. leads on 5 and Moleculin Biotech, Inc. on 4.
Valuation
Profitability
| Metric | KALA | MBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (345.32%) | (1,471.05%) | (57.72%) |
| Return on assets | (43.23%) | (152.41%) | (49.22%) |
| Return on invested capital | (722.69%) | (417.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack